Your Cart is Empty
A growing wave of litigation is hitting the makers of blockbuster weight-loss and diabetes drugs. More than 4,000 lawsuits are targeting the makers of GLP-1 medications. Numerous lawsuits claim severe health problems, ranging from sudden loss of sight and significant vision impairment to neurological disorders and reduced motor control and debilitating gastrointestinal harm.
These drugs have surged in popularity because they suppress appetite and promote weight loss. They work like a natural hormone that slows digestion, triggers insulin release, and helps people feel full longer, while also showing promise for kidney disease and addiction treatment.
It is estimated that over 30 million people have turned to GLP-1 medications for diabetes treatment or weight reduction. Common side effects including nausea, vomiting, and diarrhea are well documented, but clinical studies, safety reports, and continued research have also identified potentially serious complications linked to these medications.
The lawsuits accuse manufacturers of not fully informing doctors and patients about serious risks linked to the drugs. Plaintiffs describe severe complications that led to intensive treatment, urgent surgeries, and in certain cases, lifelong injuries.
Although the FDA has expanded warnings on some drugs to highlight risks, many believe the full scope of health conditions linked to these drugs has yet to be adequately communicated, meaning patients may still be harmed.
Drugmakers continue to stand by the safety of these medications, saying they will challenge the lawsuits.
According to a recent study, less than 25% of people get enough daily flavanols to significantly lower their risk of heart disease.Repeating the same five fruits and vegetables daily often fails to supply the necessary variety of antioxidants.
When we think about healthy aging, strong bones are usually associated with preventing fractures and staying active. But there may be another reason to pay attention to bone health. A study has found that over time,participants with lower spinal bone density showed more noticeable changes in both cognitive function and white matter in the brain.
Chronic kidney disease (CKD) is a long-term condition that is often referred to as an invisible threat because it can develop for years without obvious symptoms. The disease is a growing global health challenge, ranking as the ninth leading cause of death today. An estimated 9 out of 10 people with CKD don't know they have it, with many receiving a diagnosis only after their kidneys have been severely damaged and dialysis or a transplant becomes necessary.